ANDA 89174, held by Hospira. Methylprednisolone Sodium Succinate.
As of Nov 20, 2026, ANDA 89174 (A-Methapred), held by Hospira, was first approved by FDA on Aug 18, 1987, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 18, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| A-MethapredEQ 1GM BASE/VIAL · injectable;injection | Methylprednisolone Sodium Succinate | Discontinued |
| Oct 23, 1997 | Supplement 14Manufacturing | Approved | None posted |
| May 10, 1995 | Supplement 12Manufacturing | Approved | None posted |
| Mar 17, 1994 | Supplement 11Labeling | Approved | None posted |
| Feb 4, 1994 | Supplement 10Manufacturing | Approved | None posted |
| Oct 13, 1993 | Supplement 9Labeling | Approved | None posted |
| Oct 30, 1992 | Supplement 8Manufacturing | Approved | None posted |
| Mar 6, 1992 | Supplement 7Manufacturing | Approved | None posted |
| Jan 10, 1992 | Supplement 6Labeling | Approved | None posted |
| Aug 19, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Nov 20, 1990 | Supplement 4Manufacturing | Approved | None posted |
| Aug 9, 1990 | Supplement 3Manufacturing | Approved | None posted |
| Aug 3, 1989 | Supplement 5Labeling | Approved | None posted |
| Aug 18, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters